Parental trust in clinicians drove RSV vaccine uptake, while confusion and limited access to reliable information hindered ...

The largest US real-world study of BEYFORTUS (nirsevimab-alip) 50mg and 100mg Injection successfully met both of its co-primary endpoints, demonstrating that BEYFORTUS provides protection for babies ...

A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...

The deal seeks to strengthen the drugmaker’s portfolio of respiratory vaccines and help it move on from pipeline setbacks.

A large-scale real-world study in the USA has reinforced the effectiveness of Beyfortus (nirsevimab-alip), the respiratory ...

Find out whether you should get the RSV vaccine, known as Abrysvo, during pregnancy and when it's recommended.

That means that if pediatricians have only VFC-supplied Beyfortus in stock and need a dose for a baby who is not eligible for VFC coverage, they could use the dose, so long as they replace it.

When Beyfortus was approved over the summer, AstraZeneca and Sanofi, the two companies that manufacture the drug, said it would be available for babies in time for RSV season this year.

Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season . Paris, June 9, 2025.Sanofi is shipping Beyfortus (nirsevimab) starting in ...

New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants Paris, October 9, 2024. Sanofi advances its ambition to protect all ...

This new drug, Beyfortus, will not only help lift some of the stress doctors deal with, but also keep hospitalizations down. It would be given to babies that come through hospitals, and would ...